AIA Life Insurance Launches New Exclusive Product for Existing Customers with Full, Unreduced Coverage for Two Major Diseases
On April 2, AIA Life Insurance announced the launch of the '(Non-Reduction) Brain and Heart Immediate Care Health Insurance' to further strengthen coverage for senior customers. This new product provides comprehensive protection, including not only full, unreduced diagnosis benefits for two major diseases, but also treatment and nursing care costs. The '(Non-Reduction) Brain and Heart Immediate Care Health Insurance' is an exclusive, telecom-only product available only to existing AIA Life Insurance customers.
For customers who are already enrolled in AIA Life Insurance's two major disease coverage, if they newly enroll in this product and are diagnosed with stroke or acute myocardial infarction, they will receive 100% of the diagnosis benefit immediately, with no reduction. In addition, the newly introduced 'Major Cardiovascular and Cerebrovascular Disease Treatment Rider (Renewable Type)' provides integrated coverage for surgeries related to cardiovascular and cerebrovascular diseases, including both covered and non-covered medical expenses, thrombolytic therapy for cerebrovascular diseases, thrombolytic therapy for certain heart diseases, and intensive care unit treatment for cardiovascular and cerebrovascular diseases at general hospitals.
Notably, this rider offers coverage for more than 50 types of cardiovascular and cerebrovascular disease treatments, which is the broadest in the industry. Customers can receive benefits for up to four treatments per year, respectively. If all four types of treatments are received in a year, the maximum benefit is up to 64 million won. The benefit count resets annually during the coverage period, making it possible for customers to be prepared for repeated treatments without financial burden.
Furthermore, considering the characteristics of cardiovascular and cerebrovascular diseases that may lead to aftereffects or long-term care, the product has been designed to enhance coverage for nursing care costs associated with these diseases. This aims to alleviate the potential burden of nursing care that may arise after treatment.
Existing AIA Life Insurance customers can enroll in the product through a simplified health questionnaire (simplified underwriting), and can choose between general underwriting or simplified underwriting depending on their health status.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Shinok Yoo, Chief Customer Officer at AIA Life Insurance, stated, "We aimed to minimize coverage gaps in existing insurance by newly adding unreduced diagnosis benefits for two major diseases for existing customers, in addition to the previously available unreduced cancer diagnosis benefit, and by enhancing coverage for treatment costs of cardiovascular and cerebrovascular diseases that often require repeated treatments." She added, "In line with the super-aged society, we will continue to provide essential coverage for senior customers and deliver new customer experiences through differentiated healthcare services."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.